awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q38325894-4E75847B-1CFF-46F4-AAC1-D884F4A00DAC
Q38325894-4E75847B-1CFF-46F4-AAC1-D884F4A00DAC
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38325894-4E75847B-1CFF-46F4-AAC1-D884F4A00DAC
GPR40 agonists for the treatment of type 2 diabetes: life after 'TAKing' a hit.
P2860
Q38325894-4E75847B-1CFF-46F4-AAC1-D884F4A00DAC
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38325894-4E75847B-1CFF-46F4-AAC1-D884F4A00DAC
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
10eb7d219744893c7c93da698ac1dfa2aa428693
P2860
TAK-875, an orally available G protein-coupled receptor 40/free fatty acid receptor 1 agonist, enhances glucose-dependent insulin secretion and improves both postprandial and fasting hyperglycemia in type 2 diabetic rats.